Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Regulation of IL-22BP in psoriasis.

Authors:
Stefanos Voglis Sonja Moos Luise Kloos Florian Wanke Morad Zayoud Penelope Pelczar Anastasios D Giannou Silvia Pezer Michael Albers Felix Luessi Samuel Huber Knut Schäkel Florian C Kurschus

Sci Rep 2018 03 23;8(1):5085. Epub 2018 Mar 23.

Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.

IL-22 is a potent pro-inflammatory cytokine upregulated in psoriasis and in other inflammatory diseases. The function of IL-22 is regulated by the soluble scavenging receptor, IL-22 binding protein (IL-22BP or IL-22RA2). However, the role and regulation of IL-22BP itself in the pathogenesis of inflammatory disease remain unclear. We used the TLR7 agonist Imiquimod (IMQ) to induce a psoriasis-like skin disease in mice and found a strong downregulation of IL-22BP in the affected skin as well as in the lymph nodes of animals treated with IMQ. We also analysed psoriatic skin of patients and compared this to skin of healthy donors. Interestingly, IL-22BP expression was similarly downregulated in skin biopsies of psoriasis patients compared to the skin of healthy donors. Since IL-22BP is expressed foremost in dendritic cells, we characterized its expression in monocyte-derived dendritic cells (MoDC) during maturation. In this way, we found Prostaglandin E2 (PGE) to be a potent suppressor of IL-22BP expression in vitro. We conclude that regulation of IL-22BP by inflammatory mediators is an important step for the progression of inflammation in the skin and possibly also in other autoimmune diseases.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-23510-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865214PMC
March 2018

Publication Analysis

Top Keywords

regulation il-22bp
12
compared skin
8
dendritic cells
8
healthy donors
8
patients compared
8
il-22bp expression
8
skin healthy
8
skin
7
il-22bp
7
psoriatic skin
4
skin patients
4
interestingly il-22bp
4
downregulated skin
4
expression downregulated
4
analysed psoriatic
4
donors interestingly
4
treated imq
4
mice strong
4
strong downregulation
4
disease mice
4

Keyword Occurance

Similar Publications

Group 3 Innate Lymphoid Cells Program a Distinct Subset of IL-22BP-Producing Dendritic Cells Demarcating Solitary Intestinal Lymphoid Tissues.

Authors:
Fabian Guendel Michael Kofoed-Branzk Konrad Gronke Caroline Tizian Mario Witkowski Hung-Wei Cheng Gitta Anne Heinz Frederik Heinrich Pawel Durek Paula S Norris Carl F Ware Christiane Ruedl Susanne Herold Klaus Pfeffer Thomas Hehlgans Ari Waisman Burkhard Becher Anastasios D Giannou Sebastian Brachs Karolina Ebert Yakup Tanriver Burkhard Ludewig Mir-Farzin Mashreghi Andrey A Kruglov Andreas Diefenbach

Immunity 2020 11;53(5):1015-1032.e8

Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany; Berlin Institute of Health (BIH), Anna-Louisa-Karsch Strasse 2, 10117 Berlin, Germany; Mucosal and Developmental Immunology, Deutsches Rheuma-Forschungszentrum (DRFZ), an institute of the Leibniz Association, 10117 Berlin, Germany. Electronic address:

Solitary intestinal lymphoid tissues such as cryptopatches (CPs) and isolated lymphoid follicles (ILFs) constitute steady-state activation hubs containing group 3 innate lymphoid cells (ILC3) that continuously produce interleukin (IL)-22. The outer surface of CPs and ILFs is demarcated by a poorly characterized population of CD11c cells. Using genome-wide single-cell transcriptional profiling of intestinal mononuclear phagocytes and multidimensional flow cytometry, we found that CP- and ILF-associated CD11c cells were a transcriptionally distinct subset of intestinal cDCs, which we term CIA-DCs. Read More

View Article and Full-Text PDF
November 2020
Similar Publications

Microbiota-Dependent Effects of IL-22.

Authors:
Morsal Sabihi Marius Böttcher Penelope Pelczar Samuel Huber

Cells 2020 09 29;9(10). Epub 2020 Sep 29.

I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.

Cytokines are important contributors to immune responses against microbial and environmental threats and are of particular importance at epithelial barriers. These interfaces are continuously exposed to external factors and thus require immune components to both protect the host from pathogen invasion and to regulate overt inflammation. Recently, substantial efforts have been devoted to understanding how cytokines act on certain cells at barrier sites, and why the dysregulation of immune responses may lead to pathogenesis. Read More

View Article and Full-Text PDF
September 2020
Similar Publications

Interleukin-22 (IL-22) Binding Protein Constrains IL-22 Activity, Host Defense, and Oxidative Phosphorylation Genes during Pneumococcal Pneumonia.

Authors:
Giraldina Trevejo-Nunez Waleed Elsegeiny Felix E Y Aggor Jamie L Tweedle Zoe Kaplan Pranali Gandhi Patricia Castillo Annabel Ferguson John F Alcorn Kong Chen Jay K Kolls Sarah L Gaffen

Infect Immun 2019 11 18;87(11). Epub 2019 Oct 18.

Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

is the most common cause of community-acquired pneumonia worldwide, and interleukin-22 (IL-22) helps contain pneumococcal burden in lungs and extrapulmonary tissues. Administration of IL-22 increases hepatic complement 3 and complement deposition on bacteria and improves phagocytosis by neutrophils. The effects of IL-22 can be tempered by a secreted natural antagonist, known as IL-22 binding protein (IL-22BP), encoded by To date, the degree to which IL-22BP controls IL-22 in pulmonary infection is not well defined. Read More

View Article and Full-Text PDF
November 2019
Similar Publications

IL-18/IL-18BP and IL-22/IL-22BP: Two interrelated couples with therapeutic potential.

Authors:
Heiko Mühl Malte Bachmann

Cell Signal 2019 11 8;63:109388. Epub 2019 Aug 8.

pharmazentrum frankfurt/ZAFES, University Hospital Goethe University Frankfurt am Main, Theodor-Stern- Kai 7, 60590 Frankfurt am Main, Germany.

Interleukin (IL)-18 and IL-22 are key components of cytokine networks that play a decisive role in (pathological) inflammation, host defense, and tissue regeneration. Tight regulation of cytokine-driven signaling, inflammation, and immunoactivation is supposed to enable nullification of a given deleterious trigger without mediating overwhelming collateral tissue damage or even activating a cancerous face of regeneration. In fact, feedback regulation by specific cytokine opponents is regarded as a major means by which the immune system is kept in balance. Read More

View Article and Full-Text PDF
November 2019
Similar Publications

Regulation and function of IL-22 in peritoneal adhesion formation after abdominal surgery.

Authors:
Qingbo Wang Yongming Huang Rui Zhou Ke Wu Wei Li Liang Shi Zefeng Xia Kaixiong Tao Guobin Wang Geng Wang

Wound Repair Regen 2020 01 13;28(1):105-117. Epub 2019 Jun 13.

Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Peritoneal adhesion occurs frequently after gastrointestinal/gynecological surgery. Tissue repair and regeneration are very important during this process. IL-22 is an important cytokine that is secreted from immune cells but functions on mesenchymal cells, such as mesothelial cells. Read More

View Article and Full-Text PDF
January 2020
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap